Enterprise Financial Services Corp Sage Therapeutics, Inc. Put Options Transaction History
Enterprise Financial Services Corp
- $184 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SAGE
# of Institutions
219Shares Held
49.5MCall Options Held
175KPut Options Held
380K-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$38.9 Million4.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$28.3 Million0.0% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$23.7 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$18.1 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...